TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Arakus Yobei
Country: Reunion
Language: English (Spanish)
Genre: Literature
Published (Last): 22 June 2015
Pages: 291
PDF File Size: 6.88 Mb
ePub File Size: 20.82 Mb
ISBN: 599-6-13162-138-4
Downloads: 48344
Price: Free* [*Free Regsitration Required]
Uploader: Kara

Microparticules biodegradables pour administration soutenue de medicaments therapeutiques.

EPA1 – Acide nucléique auto-gélatinisable – Google Patents

Efficient, high-throughput production of human proteins in bacteria. Modulation de la reconnaissance d’exons dans le pre-arnm par interference avec la structure d’arn secondaire. Deciphering human protein families: Recent advances in the stereocontrolled nuclieque of antisense phosphorothioates. Intranasal administration of modulators of hypothalamic ATP-sensitive potassium channels.

Secuencia oligoribonucleotidica homologa a una region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes. US Ref document number: Kind code of ref document: CA CAC fr Sondas para construir polimeros de sondas, procedimiento para construir un polimero de sondas y uso del mismo. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery.

Antisense oligomers and methods for inducing immune tolerance and immunosuppression. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein.


Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery.

EPA1 – Acide nucléique antisens – Google Patents

Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression. CN CNB zh EP EPA2 fr EP EPB1 fr Antisense oligomers and methods for inducing immune tolerance and immunosuppression. Antisense oligonucleotides for inducing exon skipping and methods of use thereof. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.

Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres. Extended dicer substrate agents and methods for the specific inhibition of gene expression.

Solution hybridization of nucleic acids with antisense probes having modified backbones. Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof.

nhcleique Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant nuclique potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

Amorces de diagnostic et procede de detection des sous-types h5 et h5n1 du virus de la grippe aviaire. Immobilizing and processing specimens on matrix materials for the identification of nucleic acid sequences. Method for isolating biomolecules from a biological sample with linear polymers. Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine. Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof.

Procede servant a produire une preparation complexe contenant des acides nucleiques. Polymeres non charges a base de morpholine ayant des liaisons nucleiuqe phosphoreuses entre les sous-unites. Methods for amplifying and detecting multiple polynucleotides on a solid phase support. Request for preliminary examination filed prior to expiration of 19th month from priority date pct application filed from AU Date of ref document: Kind code of ref document: Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations.


EP2700414A1 – Acide nucléique auto-gélatinisable – Google Patents

Date of ref nucleiqhe Variable-speed wind power system with improved energy capture via multilevel conversion. CA CAA1 fr Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples. In situ forming implants—an attractive formulation principle for parenteral depot formulations.

A1 Designated state s: Acide ribonucleique double brin presentant une efficacite accrue dans un organisme. Composition renfermant de fines particules supportant un principe biologiquement actif ou dont ledit principe actif est maintenu par de telles particules, et procede de preparation.

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid. Dosages d’hybridation par la reaction en chaine de la polymerase specifiques a des retrovirus integres.

US USB2 en